Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.0150 (2.24%) ($4.7600 - $5.0700) on Thu. Jul. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.55% (three month average) | RSI | 65 | Latest Price | $5.0150(2.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.2% a day on average for past five trading days. | Weekly Trend | BCRX advances 8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) PEJ(12%) JETS(9%) ACES(8%) EWP(8%) IWN(8%) | Factors Impacting BCRX price | BCRX will decline at least -3.775% in a week (0% probabilities). VCIT(-7%) SHY(-7%) BNDX(-7%) VCSH(-6%) USO(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.775% (StdDev 7.55%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.9(2.35%) | 10 Day Moving Average | $4.56(9.98%) | 20 Day Moving Average | $4.43(13.21%) | To recent high | -10.2% | To recent low | 0% | Market Cap | $885m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |